Forensic Analysis · Healthcare / Pharmaceuticals / Biotech · as of Jun 28, 2026
ACCENDRA HEALTH INC/VA/ (ACH)
A forensic read on ACCENDRA HEALTH INC/VA/ built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
D · Weak — demands caution
Forensic grade
Distress
Financial health
-2.6
Altman Z-score
Clean
Earnings quality
5
Forensic signals
-50.9%
ROE
$256M
Market cap
ACCENDRA HEALTH INC/VA/ earns a D (Weak — demands caution) forensic quality grade, and its Altman Z-score is -2.6, placing it in the Distress zone. 5 forensic signals were flagged in its latest SEC filings, led by return on invested capital.
What the filings flag
1%Return on invested capital.Return on invested capital is 1% and slipping from 4% — well below its ~10% cost of capital, so reinvested dollars may be destroying value, not building it.
stoppedShareholder returns — halted.Capital returns have STOPPED — $731,000 of buybacks + dividends in FY2021, but ~$0 in FY2023. A halt usually means the company is conserving cash; understand why before reading it as neutral.
suspendedDividend — suspended.The dividend has been SUSPENDED — $731,000 paid in FY2021, then $0 in FY2023. A suspension is a major signal the board is conserving cash; the prior payment history doesn't offset it.
+0.3%/yrShare-count dilution.Diluted share count changed +1% over the last 3 years to FY2025 (+0.3%/yr). Roughly flat — buybacks are about offsetting stock comp, not shrinking the count. Per-share value isn't being meaningfully helped or hurt by the count.
$307MGoodwill impairments.Took $307M of goodwill writedowns across 1 year(s) (FY2024 ($307M)). Writedowns mean past acquisitions underperformed what was paid for them — worth weighing on capital-allocation skill.
Key fundamentals
Net Margin-39.8%
Free Cash Flow$-29.5M
Latest Revenue$2.76B
Revenue Growth YoY+3.1%
Go deeper — free with an account
The forensic grade and screens above are free — no account needed. An account adds the full interactive deep-dive on ACCENDRA HEALTH INC/VA/:
🔒The written investment read — what the numbers mean, in plain English
🔒Ask anything about ACH's filings — AI Q&A across the 10-K, 10-Qs & 8-Ks
🔒Interactive valuation — reverse-DCF sliders, Monte Carlo & scenario stress
🔒Calibrated 12-month price forecast, with the math shown